Global Life Science Ventures Investing in the life sciences

Global Life Science Ventures (GLSV) is a leading, independent venture capital fund focusing exclusively on the life sciences. GLSV is dedicated to supporting early-stage groups, originating from universities, scientific institutions or industry. The fund may also invest in selected later stage companies, including buy-outs. For this purpose, GLSV provides finance, advice and access to expertise and networks. The group currently advises and manages funds totalling more than 200 million. With offices in Germany and Switzerland, GLSV acts as one team with a global perspective.

Text size

A balanced portfolio

serving a global industry
balanced industry sector distribution

The pharmaceutical, medical technology and biotechnology industries are global businesses. Companies are increasingly looking beyond national borders for scientific collaborations, funding opportunities, R&D partnerships and merger possibilities. GLSV tries to identify and support companies that have the potential to become leaders in their markets. To maximise possible returns on investments and manage risk, GLSV also tries to ensure a balanced industry sector distribution that reflects the trends in technological innovation. A global perspective is provided by syndicate partnerships with leading US-based funds.